Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow
NCT00018304 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-01-21
Summary
The overall objective of this proposal is to examine the contribution of changes in total body fat, enhancement in insulin-mediated vasodilatation and enhancement in endothelium-derived nitric oxide production to the improvements in metabolic insulin action. In addition, the study will track whether these improvements are related to changes in blood pressure.
Conditions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Arthur Leon, M.D.
-
Alan Blank, M.D.
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Insulin Secretion in Diabetes Before and After Glycemic Control
NCT00469833 ·Status: COMPLETED ·Phase: NA
-
Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes
NCT01680133 ·Status: COMPLETED
-
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
NCT03617458 ·Status: COMPLETED ·Phase: PHASE2
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
NCT04118374 ·Status: COMPLETED ·Phase: NA
-
Influence of Central Nervous Insulin Sensitivity on Insulin Secretion
NCT02870361 ·Status: COMPLETED ·Phase: NA
-
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
NCT03383822 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metabolomic Analysis of Hepatic Insulin Resistance
NCT01833403 ·Status: COMPLETED ·Phase: NA
-
Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up
NCT01412554 ·Status: COMPLETED
-
Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)
NCT06144255 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
NCT01479075 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin and Insulin Pulses During Fasting
NCT06424015 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
NCT05478707 ·Status: SUSPENDED ·Phase: PHASE2
-
Role of Angiotensin II in Insulin-induced Microvascular Activity
NCT01024543 ·Status: COMPLETED ·Phase: NA
-
The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes
NCT06426823 ·Status: COMPLETED ·Phase: NA
-
The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans
NCT04461015 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
NCT02468999 ·Status: COMPLETED ·Phase: NA
-
Exercise and GLP-1 RA on Insulin Secretion
NCT04383197 ·Status: UNKNOWN ·Phase: NA
-
Relative Contribution of Brain Insulin Action for Postprandial Metabolism
NCT06295640 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"
NCT03929419 ·Status: COMPLETED ·Phase: NA
-
Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
NCT02127047 ·Status: COMPLETED ·Phase: PHASE2
-
Inpatient Diabetes on Corticosteroids
NCT01970241 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes
NCT06424106 ·Status: RECRUITING ·Phase: NA
-
Incretin Effect in Lean and Obese Subjects
NCT00803296 ·Status: COMPLETED